| scholarly article | Q13442814 |
| P50 | author | Gabriel N Hortobagyi | Q88225186 |
| Sharon H. Giordano | Q55640731 | ||
| Shenying Fang | Q61993774 | ||
| P2093 | author name string | Tomasz P Srokowski | |
| P2860 | cites work | A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer | Q77936234 |
| Impact of diabetes mellitus on outcomes in patients with colon cancer | Q78863604 | ||
| A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
| Identifying persons with diabetes using Medicare claims data | Q31443172 | ||
| Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer | Q33345743 | ||
| Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older | Q34141839 | ||
| Diabetes mellitus and breast cancer | Q36026132 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. | Q36773986 | ||
| Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study | Q40512796 | ||
| Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets | Q44518582 | ||
| The effect of comorbidity on 3-year survival of women with primary breast cancer | Q46637774 | ||
| Potential for cancer related health services research using a linked Medicare-tumor registry database. | Q50125205 | ||
| Validity of certified causes of death in breast carcinoma patients | Q70121007 | ||
| Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery | Q73228937 | ||
| Stopping metastases at their source | Q73728317 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| chemotherapy | Q974135 | ||
| patient | Q181600 | ||
| P304 | page(s) | 2170-2176 | |
| P577 | publication date | 2009-03-23 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer | |
| P478 | volume | 27 |
| Q36807881 | A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival |
| Q89839031 | Antineoplastic drugs prescription during visits by adult cancer patients with comorbidities: findings from the 2010-2016 National Ambulatory Medical Care Survey |
| Q88188525 | Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials |
| Q35094977 | Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women |
| Q47619617 | Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the Spanish National Hospital Discharge Database, 2013-2014. |
| Q36059119 | Associations between Diabetes and Quality of Life among Breast Cancer Survivors |
| Q33608038 | Cancer biology in diabetes |
| Q30242051 | Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? |
| Q38684987 | Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis |
| Q35871269 | Clinical benefits of metformin in gynecologic oncology |
| Q36278107 | Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study |
| Q34662865 | Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer |
| Q46098998 | Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China. |
| Q35753728 | Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus |
| Q49409380 | Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study |
| Q36246468 | Diabetes and Breast Cancer Subtypes. |
| Q47665989 | Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System |
| Q36229115 | Diabetes and breast cancer mortality in Black women. |
| Q38000089 | Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer |
| Q35911581 | Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC) |
| Q36637909 | Diabetes and risk of cancer |
| Q34662845 | Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. |
| Q30240165 | Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis |
| Q37972673 | Diabetes, cancer, and metformin: connections of metabolism and cell proliferation |
| Q35373602 | Diabetes, diabetes treatment and breast cancer prognosis |
| Q37303867 | Diabetes, metformin, and breast cancer in postmenopausal women |
| Q34520129 | Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. |
| Q35668954 | Ethnic differences in breast cancer survival: status and determinants. |
| Q40781176 | Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study |
| Q33789362 | Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis |
| Q36416237 | Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis |
| Q61450753 | Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors |
| Q60685338 | Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer |
| Q33632814 | Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis |
| Q47933245 | Glycosylated Hemoglobin A1c and Lack of Association With Symptom Severity in Patients Undergoing Chemotherapy for Solid Tumors |
| Q35108728 | High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters |
| Q33821132 | High glucose levels promote the proliferation of breast cancer cells through GTPases |
| Q30413422 | Identifying specific chemotherapeutic agents in Medicare data: a validation study |
| Q92934591 | Impact of Diabetes on the Symptoms of Breast Cancer Survivors |
| Q36194195 | Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer |
| Q33551504 | Impact of chronic conditions on the cost of cancer care for Medicaid beneficiaries |
| Q36165176 | Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients |
| Q34609703 | Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China |
| Q42138621 | Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life |
| Q50848240 | Incidence and predictors of febrile neutropenia during chemotherapy in patients with head and neck cancer. |
| Q89590994 | Influence of Preexisting Diabetes on Survival After a Breast Cancer Diagnosis in First Nations Women in Ontario, Canada |
| Q38772800 | Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis. |
| Q45908971 | Influence of diabetes mellitus on mortality in breast cancer patients. |
| Q37738720 | Insulin, insulin resistance, obesity, and cancer |
| Q92162062 | Is Routine Recurrence Score Testing in Patients Older than 70 Years of Age Warranted? An Evaluation of the National Cancer Database After TAILORx |
| Q92428934 | Living with cancer and other chronic conditions: Patients' perceptions of their healthcare experience |
| Q33956785 | Medical comorbidities predict mortality in women with a history of early stage breast cancer |
| Q36070998 | Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. |
| Q53645576 | Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus. |
| Q35187582 | Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study |
| Q26786829 | Obesity and cancer: mechanistic insights from transdisciplinary studies |
| Q36768880 | Obesity and risk of breast cancer mortality in Hispanic and Non-Hispanic white women: the New Mexico Women's Health Study |
| Q91784691 | Obesity, Metabolic Syndrome, and Breast Cancer: From Prevention to Intervention |
| Q37200502 | Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients |
| Q35137438 | On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test. |
| Q38043963 | Perceived impact of cancer treatment on diabetes self-management. |
| Q36506987 | Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer |
| Q90055018 | Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study |
| Q39620206 | Pre-Existing Diabetes in Early Stage Breast Cancer Patients is Associated with Lack of Improvement in Quality of Life 2 Years After Diagnosis |
| Q36769486 | Pre-diagnosis blood glucose and prognosis in women with breast cancer. |
| Q36027036 | Pre-existing diabetes and breast cancer prognosis among elderly women. |
| Q36182175 | Racial disparities and colorectal cancer survival in older adults with and without diabetes mellitus |
| Q35026994 | Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres |
| Q34424031 | Relationship between diabetes and risk of second primary contralateral breast cancer |
| Q36851424 | Senior adult oncology |
| Q26777775 | The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer |
| Q50947162 | The association between diabetes and breast cancer stage at diagnosis: a population-based study. |
| Q87898837 | The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors |
| Q36060158 | The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project |
| Q38983276 | The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis |
| Q35913204 | The impact of diabetes mellitus on prognosis of early breast cancer in Asia |
| Q41499485 | The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry |
| Q44913921 | The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer |
| Q38180008 | Treatment and outcomes in diabetic breast cancer patients |
| Q90070289 | Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015 |
| Q82505332 | Type 2 diabetes mellitus and prognosis in early stage breast cancer women |
| Q94539110 | Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status |
| Q40704869 | Understanding the Association of Type 2 Diabetes Mellitus in Breast Cancer Among African American and European American Populations in South Carolina |
| Q46029514 | Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy. |
| Q92429002 | Vivre avec un cancer et d’autres maladies chroniques : perceptions des patients au sujet de leur expérience des soins de santé |
| Q47795004 | Zinc and its transporter ZIP6 are key mediators of breast cancer cell survival under high glucose conditions |
Search more.